EUCTR2017-000239-15-Outside-EU/EEA进行中（未招募）1 期
An open-label, uncontrolled 4-week study to assess the safety, efficacy and pharmacokinetics of Allegra® (dry syrup formulation)15 mg or 30 mg twice daily in pediatric patients with perennial allergic rhinitis.
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- Sanofi
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Aged 6 months through 11 years
- •Patients with perennial allergic rhinitis
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 100
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Neither serum specific IgE antibody or skin reaction is positive for the antigen of perennial allergy.
- •Nasal symptom score is 0 for either sneezing or nasal discharge, or sum of these two score is less than 3, or nasal congestion score is 4.
- •Patients with vasomotor rhinitis or eosinophilic rhinitis.
研究者
相似试验
进行中（未招募）
1 期
Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Atopic Dermatitis (AD)Atopic dermatitisEUCTR2017-000251-74-Outside-EU/EEASanofi100
招募中
1 期
An open-label, uncontrolled study to evaluate the efficacy and safety of autologous bone marrow mesenchymal stem cells (LS-ABMSC1) in patients with decompensated liver cirrhosis (Phase I / II study)Decompensated liver cirrhosisJPRN-jRCT2063200014Takami Taro10
尚未招募
2 期
An open-label, uncontrolled study to evaluate the safety and immunogenicity of FPP003 in subjects with axial spondyloarthritis (phase IIa study)Axial spondyloarthritis (ankylosing spondylitis and axial spondyloarthritis not meeting radiographicJPRN-jRCT2050230093Tsuji Shigeyoshi6
招募中
1 期
An open-label, uncontrolled study to evaluate the efficacy and safety of autologous bone marrow mesenchymal stem cells (LS-ABMSC1) in patients with decompensated liver cirrhosis (Phase I / II study)JPRN-UMIN000041461Yamaguchi University Graduate School of Medicine10
已完成
2 期
Study to evaluate the safety and efficacy of Skin care product for its non-comedogenic effectCTRI/2023/09/057974Kreative Beauty Private Limited60